Literature DB >> 5107095

Human prolactin: measurement in plasma by in vitro bioassay.

D L Kleinberg, A G Frantz.   

Abstract

Prolactin has been measured in unextracted human plasma by a sensitive and specific in vitro bioassay. Secretory activity of breast tissue fragments from mid-pregnant mice, incubated in organ culture with human plasma, serves as the histologic end point. Sensitivity is 5 ng/ml (0.14 mU/ml) or somewhat better for ovine prolactin, and approximately 0.42 mU/ml for prolactin activity of human plasma at the dilutions used in the assay. Human growth hormone as it circulates in blood, like the material extracted from pituitary glands, is strongly lactogenic. Antisera to human growth hormone are capable of completely neutralizing the prolactin effect of large amounts (600 ng/ml) of human growth hormone added to the system. Plasma prolactin activity is less than 0.42 mU/ml in normal men and women. Of 26 patients with nonpuerperal galactorrhea, 14 had elevated prolactin activities ranging from 0.42 to 3.5 mU/ml. Growth hormone levels by radioimmunoassay were far too low, in general, to account for the observed prolactin activity. All of 14 nursing mothers, 1-30 days post partum, had elevated prolactin activity with a mean of 2.29 and a total range of 0.56-4.5 mU/ml. Growth hormone was in the low normal range in all of these subjects. Seven patients on psychoactive drugs of the phenothiazine series similarly had elevated prolactin activity with low growth hormone. Antiserum to human growth hormone, when preincubated with plasma samples from each of these three groups of subjects, produced no significant inhibition of prolactin activity. In two acromegalic patients with markedly elevated growth hormone levels, antiserum to growth hormone produced complete inhibition of prolactin activity in one and partial inhibition in the other. These studies indicate that human growth hormone and human prolactin are separate molecules, with little if any immunologic cross-reactivity, at least as demonstrated by the antisera used in this study, and that their release is governed by different physiologic mechanisms.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5107095      PMCID: PMC442054          DOI: 10.1172/JCI106643

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

1.  IMMUNOASSAY OF GROWTH HORMONE IN CULTURES OF HUMAN HYPOPHYSIS BY THE METHOD OF COMPLEMENT FIXATION: COMPARISON OF THE GROWTH HORMONE SECRETION AND THE PROLACTIN ACTIVITY.

Authors:  J BRAUMAN; H BRAUMAN; J L PASTEELS
Journal:  Nature       Date:  1964-06-13       Impact factor: 49.962

2.  Prolactin activity of human growth hormone.

Authors:  K A FERGUSON; A L WALLACE
Journal:  Nature       Date:  1961-05-13       Impact factor: 49.962

3.  Syndrome characterized by galactorrhea, amenorrhea and low urinary FSH: comparison with acromegaly and normal lactation.

Authors:  A P FORBES; P H HENNEMAN; G C GRISWOLD; F ALBRIGHT
Journal:  J Clin Endocrinol Metab       Date:  1954-03       Impact factor: 5.958

4.  Effect of pregnancy on the somatotroph and the prolactin cell of the human adenohypophysis.

Authors:  L G Goluboff; C Ezrin
Journal:  J Clin Endocrinol Metab       Date:  1969-12       Impact factor: 5.958

Review 5.  Adenohypophysis:prolactin.

Authors:  J Meites; C S Nicoll
Journal:  Annu Rev Physiol       Date:  1966       Impact factor: 19.318

6.  The detection of lactogenic activity in human blood by bioassay.

Authors:  I A Forsyth
Journal:  J Endocrinol       Date:  1970-02       Impact factor: 4.286

7.  Multiple hormone interactions related to the growth and differentiation of mammary gland in vitro.

Authors:  Y J Topper
Journal:  Trans N Y Acad Sci       Date:  1968-04

8.  Correlation between immunoreactive growth hormone and prolactin activity in human and simian pituitary cell cultures.

Authors:  I L Solomon; D B Grant; I M Burr; S L Kaplan; M M Grumbach
Journal:  Proc Soc Exp Biol Med       Date:  1969-11

9.  Bio-assay of prolactin. Analysis of the pigeon crop-sac response to local prolactin injection by an objective and quantitative method.

Authors:  C S Nicoll
Journal:  Endocrinology       Date:  1967-04       Impact factor: 4.736

10.  A double-antibody radioimmunoassay procedure for ovine pituitary prolactin.

Authors:  Y Arai; T H Lee
Journal:  Endocrinology       Date:  1967-11       Impact factor: 4.736

View more
  25 in total

Review 1.  Pituitary-gonadal axis: historical notes.

Authors:  J Lindholm; E Husted Nielsen
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

2.  Effects of melperone and thiothixene on prolactin levels in cerebrospinal fluid and plasma of psychotic women.

Authors:  L Bjerkenstedt; P Eneroth; C Härnryd; G Sedvall
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1977-12-28

Review 3.  Changing concepts of prolactin in man.

Authors:  W P Vander Laan
Journal:  Calif Med       Date:  1973-02

Review 4.  Galactorrhoea.

Authors:  G M Besser; C R Edwards
Journal:  Br Med J       Date:  1972-04-29

Review 5.  Bioassay of prolactin.

Authors:  I A Forsyth
Journal:  Proc R Soc Med       Date:  1973-09

6.  Characterization of human somatotropin binding to detergent-solubilized lactogenic receptors from rat liver.

Authors:  J S Bonifacino; S H Sánchez; A C Paladini
Journal:  Biochem J       Date:  1981-02-15       Impact factor: 3.857

7.  Galactorrhoea amenorrhoea syndrome due to internal carotid artery aneurysm.

Authors:  S K Garg; R J Dash
Journal:  Postgrad Med J       Date:  1985-07       Impact factor: 2.401

8.  Galactorrhoea: successful treatment with reduction of plasma prolactin levels by brom-ergocryptine.

Authors:  G M Besser; L Parke; C R Edwards; I A Forsyth; A S McNeilly
Journal:  Br Med J       Date:  1972-09-16

Review 9.  Historical perspectives of prolactin and growth hormone as mammogens, lactogens and galactagogues--agog for the future!

Authors:  Josephine F Trott; Barbara K Vonderhaar; Russell C Hovey
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-19       Impact factor: 2.673

10.  Some properties of the goat placental lactogen.

Authors:  S Becka; J Bílek; J Slaba; J Skarda; I Mikulás
Journal:  Experientia       Date:  1977-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.